GGrantIndex
← Search

K4L SURFACTANT AEROSOL TO REDUCE INFLUENZA LUNG INJURY

$225,000N43FY2015AINIH

Discovery Laboratories, Inc., Warrington PA

Investigators

Abstract

To support the development of a broadly applicable therapy directed at modulating host factors and immune-mediated processes to reduce lung injury and immunopathology in serious influenza.

View original record on NIH RePORTER →